Search Results - "Coskun Ozer Demirtas"

High incidence of hepatitis B core antibody positivity in metabolic-associated fatty liver disease-related cirrhosis by Ergenc, Ilkay, Gokcen, Pinar, Adali, Gupse, Tarik Kani, Haluk, Ozer Demirtas, Coskun, Gunduz, Feyza, Ataizi Celikel, Cigdem, Yilmaz, Yusuf

“…The coexistence of metabolic-associated fatty liver disease (MAFLD) in the course of chronic hepatitis B virus infection increases liver-related morbidity. A…”
Get full text

Causes of erectile dysfunction in non-alcoholic fatty liver disease by Kani, Haluk Tarik, Sener, Tarik Emre, Aykut, Umut Emre, Coskun Ozer Demirtas, Caglayan Keklikkiran, Ergenc, Ilkay, Demirci, Abdullah Fatih, Haydar Kamil Cam, Celikel, Cigdem, Akbal, Cem, Duman, Deniz

“…Background and Aim: Erectile dysfunction (ED) is an important and commonly seen disorder in patients with non-alcoholic fatty liver disease (NAFLD). The…”
Get full text

Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non‐alcoholic fatty liver disease—simply associated or more complicated? by Demirtas, Coskun Ozer, Yilmaz, Yusuf

“…LINKED CONTENT This article is linked to Park et al papers. To view these articles, visit https://doi.org/10.1111/apt.16324 and…”
Get full text

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease by Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz

“…Background/Aims: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of…”
Get full text

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease by Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz

“…Background/Aims: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of…”
Get full text

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease by Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz

“…Background/Aims: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of…”
Get full text

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease by Eda Kaya, Alev Bakir, Haluk Tarik Kani, Coskun Ozer Demirtas, Caglayan Keklikkiran, Yusuf Yilmaz

“…Background/Aims: Advanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of…”
Get full text

Letter: Is female sex an independent predictor of favourable prognosis in hepatocellular carcinoma? by Demirtas, Coskun Ozer, Gunduz, Feyza

“…LINKED CONTENT This article is linked to Rich et al paper. To view these article, visit https://doi.org/10.1111/apt.15917…”
Get full text

Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice? by Coskun Ozer Demirtas, Yilmaz, Yusuf

“…Many reports highlighting its linkage to obesity, obesity-associated diseases and insulin resistance have been published. Since its original naming, NAFLD has…”
Get full text

Simple Noninvasive Scores Are Clinically Useful to Exclude, Not Predict, Advanced Fibrosis: A Study in Turkish Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease by Kaya, Eda, Bakir, Alev, Kani, Haluk Tarik, Demirtas, Coskun Ozer, Keklikkiran, Caglayan, Yilmaz, Yusuf

“…Background/AimsAdvanced fibrosis (F≥3) indicates poor outcomes in nonalcoholic fatty liver disease (NAFLD). Here, we examined the diagnostic performance of the…”
Get full text

Surveillance of hepatocellular carcinoma in cirrhotic patients: Current knowledge and future directions by Coskun Ozer Demirtas, Ozdogan, Osman Cavit

“…Patients with cirrhosis are at the highest risk to develop hepatocellular carcinoma (HCC), with a variable annual risk of 1–8%. Currently, biannual abdominal…”
Get full text

Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study by Demirtas, Coskun Ozer, Keklikkiran, Caglayan, Ergenc, Ilkay, Erturk Sengel, Buket, Eskidemir, Gunes, Cinel, Ismail, Odabasi, Zekaver, Korten, Volkan, Yilmaz, Yusuf

“…Pre-existing chronic liver disease is currently considered a poor prognostic factor for coronavirus disease 2019 (COVID-19). The present study aimed to…”
Get more information

Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease by Kani, Haluk Tarik, Demirtas, Coskun Ozer, Keklikkiran, Caglayan, Ergenc, Ilkay, Mehdiyev, Shahin, Akdeniz, Esra, Yilmaz, Yusuf

“…Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated…”
Get full text

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib by Colombatto, Piero, Demirtas, Coskun Ozer, Ricco, Gabriele, Civitano, Luigi, Boraschi, Piero, Scalise, Paola, Cavallone, Daniela, Oliveri, Filippo, Romagnoli, Veronica, Bleve, Patrizia, Coco, Barbara, Salvati, Antonio, Urbani, Lucio, Bonino, Ferruccio, Brunetto, Maurizia Rossana

“…In advanced HCC, tyrosine-kinase inhibitors obtain partial responses (PR) in some patients and complete responses (CR) in a few. Better understanding of the…”
Get full text

The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance by Coskun Ozer Demirtas, Sapmaz, Aybuke, Gurel, Burak Ahmet, Kizmaz, Hasan, Ulu, Tuncay, Karaketir, Seyma Gorcin, Hidiroglu, Seyhan, Yilmaz, Yusuf

“…Background and Aim: Non-alcoholic fatty liver disease (NAFLD) is closely associated with insulin resistance (IR). While a minority of patients with NAFLD does…”
Get full text

Clinical significance of isolated abnormal intestinal findings in magnetic resonance enterography in patients with suspected small bowel disease by Alahdab, Yesim Ozen, Demirtas, Coskun Ozer, Kani, Haluk Tarik, Tuney, Davut, Seker, Lamia, Tolu, Tugba, Atug, Ozlen

“…Purpose Magnetic resonance imaging (MRE) is a well-established adjunct diagnostic tool for the diagnosis of Crohn’s Disease (CD), as ileocolonoscopy can…”
Get full text

Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study by Ergenc, Ilkay, Kara, Erdogan, Yilmaz, Muhammed Emre, Demirtas, Coskun Ozer, Keklikkiran, Caglayan, Das, Taner, Buyuk, Yalcin, Celikel, Cigdem, Asliyuksek, Hizir, Yilmaz, Yusuf

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global epidemic in Türkiye and worldwide. The aim of this study was to evaluate…”
Get full text

Myeloperoxidase and calprotectin; Any role as non-invasive markers for the prediction of inflammation and fibrosis in non-alcoholic steatohepatitis? by Bicakci, Ercan, Demirtas, Coskun Ozer, Celikel, Cigdem, Haklar, Goncagul, Duman, Deniz Guney

“…Background/Aims: Specific serum markers reflecting hepatic inflammation and fibrosis are required to tailor the treatment strategies in non-alcoholic…”
Get full text

Practicality and potential restrictions of unresectable hepatocellular carcinoma prognostic index by Demirtas, Coskun Ozer, Ricco, Gabrielle, Ozdogan, Osman Cavit, Baltacioglu, Feyyaz, Ones, Tunc, Yumuk, Perran Fulden, Dulundu, Ender, Uzun, Sinan, Colombatto, Pierro, Oliveri, Filippo, Brunetto, Maurizia Rosanna, Gunduz, Feyza

Get full text

Can metastasis and recurrence be detected with Endocan and Vascular Endothelial Growth Factor in thyroid papillary cancer? by Hande Peynirci, Canan Ersoy, Pınar Sisman, Ozlem Saraydaroglu, Coskun Ozer Demirtas, Ozen Oz Gul

“…Background. Endocan is known to be associated with different type of malignancies and vascular endothelial growth factor (VEGF) has been shown to upregulate…”
Get full text